Hydroxyapatite incorporation into MCM-41 and study of ibuprofen drug release
- 11 Downloads
In this study, the mesoporous silica/hydroxyapatite (MCM/HA) was successfully synthesized by a simple one-step method as a controlled drug delivery system. The characterization of mesoporous materials was carried out by X-ray diffraction (XRD), transmission electron microscopy (HRTEM), Fourier-transform infrared spectroscopy (XRF), N2 adsorption/desorption analysis, and ultraviolet spectroscopy. Furthermore, ibuprofen (IBU) drug storage capacities and release rate were studied at in vitro conditions. The XRD and HRTEM results showed the formation of hydroxyapatite nanocrystals into mesoporous silica channels. The BET results indicated that the formation of hydroxyapatite into meso-channels leads to decrease in MCM-41 surface area and pore volume. In addition, the ibuprofen loading and release results showed that adsorption and release behavior of ibuprofen were extremely depended on the interaction of the MCM-41 surface groups and ibuprofen and carrier structural properties in the presence of hydroxyapatite crystals.
KeywordsMesoporous silica MCM-41 Drug release Ibuprofen Hydroxyapatite
Authors gratefully thank the Nanonafez Company in Semnan University Science and Technology Park, Shahroud Branch Islamic Azad University, and Shahroud University of Medical Science for supporting the research work.
- 1.Chen X, Wen H and Park K: Challenges and new technologies of oral controlled release. Oral Controlled Release Formulation Design and Drug Delivery. Theory to Practice. 16, 257(2010)Google Scholar
- 3.Amatya, S., Park, E.J., Park, J.H., Kim, J.S., Seol, E., Lee, H., Choi, H., Shin, Y.H., Na, D.H.: Drug release testing methods of polymeric particulate drug formulations. J. of Pharmaceutical Investigation. 43, 259–266 (2013)Google Scholar
- 7.Anderson, J., Rosenholm, J., Linden, M.: Mesoporous silica: an alternative diffusion controlled drug delivery system.Topics in Multifunctional Biomaterials and Devices, Ed. N Ashammakhi 6, 1–9 (2008).Google Scholar
- 12.Taherian, Z., Yousefpour, M., Tajally, M., Khoshandam, B.: Promotional effect of samarium on the activity and stability of Ni-SBA-15 catalysts in dry reforming of methane. Microporous Mesoporous Mater. 25, 19 (2017)Google Scholar
- 15.Cecilia, J.A., García-Sancho, C., Mérida-Robles, J.M., Santamaría-González, J., Infantes-Molina, A., Moreno-Tots, R., Maireles-Torres, P.: Aluminum doped mesoporous silica SBA-15 for glycerol dehydration to value-added chemicals. J. Sol-Gel Sci. Technol. 342, 83 (2017)Google Scholar
- 16.Ruiz-Hernández, E., Baeza, A., Vallet-Regí, M.: Smart drug delivery through DNA/magnetic nanoparticle gates. Am. Chem. Soc. 5, 1359 (2011)Google Scholar
- 19.Vallet-Regí M, Izquierdo-Barba I, Colilla M: Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery. 370, 1421(2012)Google Scholar
- 21.Vivero-Escoto, J.L., Slowing, I.I., Trewyn, B.G., Lin, V.S.Y.: Mesoporous silica nanoparticles for intracellular controlled drug delivery.Wiley Online Library. Small. 6, 1952 (2010)Google Scholar
- 27.Balas, F., Pérez-Pariente, J., Vallet-Regí, M.: In vitro bioactivity of silicon-substituted hydroxyapatites. J. of Biomedical Materials Research. A. 66, 364 (2003)Google Scholar
- 34.Li, Z., Su, K., Cheng, B., Deng, Y.: Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery. J. Colloid and Interface Science. 342, 607 (2010)Google Scholar